Trial NCT03015792

View at ClinicalTrials.gov 
Org. Study IDs: MC148A
Secondary IDs: NCI-2017-00006

Last trial update was posted on 2023-03-07

MeSH Interventions

BB 1101 Dexamethasone Dexamethasone acetate Ibrutinib Ichthammol Lenalidomide

MeSH Conditions

Multiple Myeloma Neoplasms, Plasma Cell

Other Conditions

Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma

Stopping Reasons

Per CS0139535 -submitter stated we can update status to Admin complete- low accrual reasoning

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID